Fieldpoint Private Securities’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$1K Sell
16
-40
-71% -$2.5K ﹤0.01% 1361
2022
Q1
$4K Sell
56
-88
-61% -$6.29K ﹤0.01% 1339
2021
Q4
$14K Sell
144
-8
-5% -$778 ﹤0.01% 984
2021
Q3
$13K Hold
152
﹤0.01% 962
2021
Q2
$10K Hold
152
﹤0.01% 1019
2021
Q1
$14K Hold
152
﹤0.01% 896
2020
Q4
$9K Buy
+152
New +$9K ﹤0.01% 948